166 related articles for article (PubMed ID: 33059910)
1. Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.
Winer LK; Cortez AR; Ahmad SA; Wima K; Olowokure O; Latif T; Kharofa J; Patel SH
J Surg Res; 2021 Mar; 259():442-450. PubMed ID: 33059910
[TBL] [Abstract][Full Text] [Related]
2. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
Neoptolemos JP; Stocken DD; Dunn JA; Almond J; Beger HG; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Lacaine F; Buckels J; Deakin M; Adab FA; Sutton R; Imrie C; Ihse I; Tihanyi T; Olah A; Pedrazzoli S; Spooner D; Kerr DJ; Friess H; Büchler MW;
Ann Surg; 2001 Dec; 234(6):758-68. PubMed ID: 11729382
[TBL] [Abstract][Full Text] [Related]
3. Optimal timing and treatment strategy for pancreatic cancer.
Gamboa AC; Rupji M; Switchenko JM; Lee RM; Turgeon MK; Meyer BI; Russell MC; Cardona K; Kooby DA; Maithel SK; Shah MM
J Surg Oncol; 2020 Sep; 122(3):457-468. PubMed ID: 32470166
[TBL] [Abstract][Full Text] [Related]
4. Vascular resection during pancreatectomy for pancreatic head cancer: A technical issue or a prognostic sign?
Belfiori G; Fiorentini G; Tamburrino D; Partelli S; Pagnanelli M; Gasparini G; Castoldi R; Balzano G; Rubini C; Zamboni G; Crippa S; Falconi M
Surgery; 2021 Feb; 169(2):403-410. PubMed ID: 32912782
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?
Parikh AA; Maiga A; Bentrem D; Squires MH; Kooby DA; Maithel SK; Weber SM; Cho CS; Katz M; Martin RC; Scoggins CR; Sutton J; Ahmad SA; Abbott DE; Carr J; Kim HJ; Yakoub D; Idrees K; Merchant N
J Am Coll Surg; 2016 Apr; 222(4):448-56. PubMed ID: 26895735
[TBL] [Abstract][Full Text] [Related]
6. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
Weyhe D; Obonyo D; Uslar VN; Stricker I; Tannapfel A
PLoS One; 2021; 16(3):e0248633. PubMed ID: 33735191
[TBL] [Abstract][Full Text] [Related]
8. Survival Outcomes of Adjuvant Chemotherapy Combined With Radiation Versus Chemotherapy Alone After Pancreatectomy for Distal Pancreatic Adenocarcinoma: A Single-Institution Experience.
Batukbhai B; Herman JM; Zahurak M; Laheru DA; Le DT; Wolfgang CL; Zheng L; De Jesus-Acosta A
Pancreas; 2021 Jan; 50(1):64-70. PubMed ID: 33370024
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-Subset analysis of the ESPAC-1 data.
Carter R; Stocken DD; Ghaneh P; Bramhall SR; Olah A; Kelemen D; Bassi C; Friess H; Dervenis C; Spry N; Büchler MW; Neoptolemos JP;
Int J Cancer; 2009 Jun; 124(12):2960-5. PubMed ID: 19330830
[TBL] [Abstract][Full Text] [Related]
10. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for pancreatic cancer.
Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
[TBL] [Abstract][Full Text] [Related]
12. Trends in the use of evidence-based therapy for resectable gastric cancer.
Snyder RA; Penson DF; Ni S; Koyama T; Merchant NB
J Surg Oncol; 2014 Sep; 110(3):285-90. PubMed ID: 24891231
[TBL] [Abstract][Full Text] [Related]
13. Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?
Ostapoff KT; Gabriel E; Attwood K; Kuvshinoff BW; Nurkin SJ; Hochwald SN
HPB (Oxford); 2017 Jul; 19(7):587-594. PubMed ID: 28433254
[TBL] [Abstract][Full Text] [Related]
14. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Cloyd JM; Crane CH; Koay EJ; Das P; Krishnan S; Prakash L; Snyder RA; Varadhachary GR; Wolff RA; Javle M; Shroff RT; Fogelman D; Overman M; Wang H; Maitra A; Lee JE; Fleming JB; Katz MH
Cancer; 2016 Sep; 122(17):2671-9. PubMed ID: 27243381
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
Stocken DD; Büchler MW; Dervenis C; Bassi C; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Neoptolemos JP;
Br J Cancer; 2005 Apr; 92(8):1372-81. PubMed ID: 15812554
[TBL] [Abstract][Full Text] [Related]
16. Trends in the treatment of resectable pancreatic adenocarcinoma.
Raigani S; Ammori J; Kim J; Hardacre JM
J Gastrointest Surg; 2014 Jan; 18(1):113-23. PubMed ID: 24002769
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy in pancreatic cancer.
Jones OP; Melling JD; Ghaneh P
World J Gastroenterol; 2014 Oct; 20(40):14733-46. PubMed ID: 25356036
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival.
Morganti AG; Cellini F; Buwenge M; Arcelli A; Alfieri S; Calvo FA; Casadei R; Cilla S; Deodato F; Di Gioia G; Di Marco M; Fuccio L; Bertini F; Guido A; Herman JM; Macchia G; Maidment BW; Miller RC; Minni F; Passoni P; Valentini C; Re A; Regine WF; Reni M; Falconi M; Valentini V; Mattiucci GC
BMC Cancer; 2019 Jun; 19(1):569. PubMed ID: 31185957
[TBL] [Abstract][Full Text] [Related]
19. Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally.
Lutfi W; Zenati MS; Zureikat AH; Zeh HJ; Hogg ME
Ann Surg Oncol; 2018 Jul; 25(7):1860-1867. PubMed ID: 29691733
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy for pancreatic cancer.
Ghaneh P; Slavin J; Sutton R; Neoptolemos JP
Swiss Surg; 2000; 6(5):289-95. PubMed ID: 11077498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
